Clarifications on the safety of dexrabeprazole vs. omeprazole in the treatment of gastroesophageal reflux disease

Gac Med Mex. 2023;159(4):364-365. doi: 10.24875/GMM.M23000798.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Gastroesophageal Reflux* / drug therapy
  • Humans
  • Omeprazole* / adverse effects
  • Rabeprazole

Substances

  • Omeprazole
  • Rabeprazole